Black Diamond Therapeutics, Inc. (BDTX) stock
BDTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.47−0.05 (-3.29%)
Close on Nov 13, 2026Market cap $84.46MP/E –Yield –
Black Diamond Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Black Diamond Therapeutics's price to sales ratio was 2.2× on Apr 30, 2026.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 2.2× | +0.2 |
| 2025 | Dec 31, 2025 | 2.0× | – |
See a number that looks wrong?